1. Home
  2. LOVE vs CCCC Comparison

LOVE vs CCCC Comparison

Compare LOVE & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$15.42

Market Cap

193.2M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.40

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOVE
CCCC
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
185.1M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
LOVE
CCCC
Price
$15.42
$4.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$25.00
$12.20
AVG Volume (30 Days)
110.0K
2.8M
Earning Date
06-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
0.28
N/A
Revenue
$697,115,000.00
$35,947,000.00
Revenue This Year
$4.63
N/A
Revenue Next Year
$6.40
N/A
P/E Ratio
$57.75
N/A
Revenue Growth
2.42
1.02
52 Week Low
$10.33
$1.27
52 Week High
$21.06
$3.97

Technical Indicators

Market Signals
Indicator
LOVE
CCCC
Relative Strength Index (RSI) 47.76 71.85
Support Level $14.04 $2.13
Resistance Level $16.25 N/A
Average True Range (ATR) 0.62 0.36
MACD -0.03 0.07
Stochastic Oscillator 35.81 84.31

Price Performance

Historical Comparison
LOVE
CCCC

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: